Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
    • JVI Classic Spotlights
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
    • JVI Classic Spotlights
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
VIRAL PATHOGENESIS AND IMMUNITY

Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine

Ralph A. Tripp, Larry J. Anderson
Ralph A. Tripp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry J. Anderson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1.

    RSV-specific CTLp frequencies for MHC class I- and II-restricted lymphocytes isolated from BAL fluid of BALB/c mice at various time points post-i.n. infection with RSV or an HPIV3 controla

    No. of days p.i.bVirusMHC classCTLp frequency rangec
    3RSVI>106
    3RSVII 106
    5RSVI1:46,500–1:50,200
    5RSVII1:145,000–1:162,100
    7RSVI1:5,300–1:6,500
    7RSVII1:22,800–1:28,500
    7HPIV3I>106
    10RSVI1:2,800–1:6,300
    10RSVII1:25,500–1:32,200
    10HPIV3I>106
    14RSVI1:2,500–1:7,500
    14RSVII1:12,500–1:38,000
    48RSVI1:120,800–1:230,000
    48RSVII1:210,500–1:>106
    • a Three individual mice were examined at each time point for the frequencies of class I-and II-restricted CTLps, and the range of frequencies is shown.

    • b Number of days after RSV infection.

    • c The 95% confidence limits for all of the CTLp frequencies shown ranged from 1,200 to 26,300. The limiting-dilution protocol used 51Cr-labeled, RSV-infected target cells and uninfected target cells to determine the background. The values for uninfected targets were always >1:500,000 and are not shown. The CTLp frequency for naive animals was >1:106.

  • Table 2.

    RSV-specific CTLp frequencies for MHC class I- and II-restricted lymphocytes isolated from the spleens of BALB/c mice at various time points post-i.n. infection with RSV or an HPIV3 controla

    No. of days p.i.bVirusMHC classCTLp frequency rangec
    3RSVI>106
    3RSVII>106
    4RSVI1:29,200–1:37,900
    4RSVII1:71,800–1:75,700
    5RSVI1:2,200–1:8,300
    5RSVII1:2,300–1:12,100
    7RSVI1:4,800–1:6,000
    7RSVII1:5,500–1:6,300
    7HPIV3I>106
    10RSVI1:5,000–1:6,300
    10RSVII1:2,000–1:2,900
    10HPIV3I>106
    12RSVI1:4,000–1:6,400
    12RSVII1:2,200–1:3,300
    48RSVI1:26,900–1:33,400
    48RSVII1:14,200–1:21,200
    • a Three individual mice were examined at each time point for the frequencies of class I-and II-restricted CTLps, and the range of frequencies is shown.

    • b Number of days after RSV infection.

    • c The 95% confidence limits for all of the CTLp frequencies shown ranged from 710 to 1,800. The limiting-dilution protocol used 51Cr-labeled, RSV-infected target cells and uninfected target cells to determine the background. The values for uninfected targets were always >1:500,000 and are not shown. The CTLp frequency for naive animals was >1:106.

  • Table 3.

    RSV-specific CTLp frequencies for MHC class I- and II-restricted lymphocytes isolated from the spleens of BALB/c mice at various time points postvaccination with FI-RSV or an FI-HPIV3 controla

    No. of days p.i.bAgMHC classCTLp frequency rangec
    3FI-RSVI>106
    3FI-RSVII>106
    4FI-RSVI1:147,000–1:365,300
    4FI-RSVII1:21,600–1:43,400
    5FI-RSVI1:80,500–1:183,000
    5FI-RSVII1:8,800–1:10,900
    7FI-RSVI1:28,300–1:55,600
    7FI-RSVII1:2,000–1:3,800
    7FI-HPIV3I>106
    10FI-RSVI1:14,600–1:18,700
    10FI-RSVII1:1,700–1:3,300
    10FI-HPIV3I>106
    12FI-RSVI1:15,800–1:31,100
    12FI-RSVII1:1,500–1:2,600
    48FI-RSVI1:38,500–1:65,200
    48FI-RSVII1:2,700–1:3,900
    • a Three individual mice were examined at each time point for the frequencies of class I-and II-restricted CTLps, and the ranges are shown.

    • b Number of days after immunization with FI-RSV.

    • c The 95% confidence limits for class I-restricted CTLps ranged from 1,000 to 9,000. The 95% confidence limits for class II-restricted CTLPs ranged from 720 to 1,300. The limiting-dilution protocol used 51Cr-labeled, RSV-infected target cells and uninfected target cells to determine the background. The values for uninfected targets were always >1:500,000 and are not shown.

  • Table 4.

    RSV-specific CTLp frequencies for MHC class I- and II-restricted lymphocytes isolated from the spleens of BALB/c mice challenged with RSV or HPIV3 3 weeks after intramuscular immunization with FI-RSV or FI-HPIV3a

    No. of days p.i.bVirusMHC classCTLp frequency rangec
    PrimarySecondary
    0FI-RSVI1:111,300–1:113,600
    0FI-RSVII1:11,900–1:12,200
    3FI-RSVRSVI1:12,600–1:14,400
    3FI-RSVRSVII1:19,700–1:24,600
    4FI-RSVRSVI1:2,300–1:3,900
    4FI-RSVRSVII1:8,200–1:12,700
    6FI-RSVRSVI1:980–1:5,700
    6FI-RSVRSVII1:3,100–1:8,200
    3RSVI>106
    3RSVII>106
    6RSVI1:4,800–1:6,000
    6RSVII1:5,800–1:6,500
    0FI-HPIV3I>106
    3FI-HPIV3RSVI>106
    5FI-HPIV3RSVI1:14,200–1:24,900d
    3HPIV3I>106
    5HPIV3I>106
    3FI-HPIV3HPIV3I1:856,300–>106
    5FI-HPIV3HPIV3I>106
    • a Three individual mice were examined at each time point for the frequencies of class I-and II-restricted CTLps, and the frequency ranges are shown.

    • b Number of days after RSV challenge.

    • c The 95% confidence limits for the CTLp frequencies shown ranged from 680 to 1,800. The limiting-dilution protocol used 51Cr-labeled, RSV-infected target cells and uninfected target cells to determine the background. The values for uninfected targets were always >1:500,000 and are not shown. The RSV-specific CTLp frequencies for age-matched control mice infected with RSV alone are shown.

    • d The 95% confidence limits for the CTLp frequencies shown ranged from 500 to 720.

PreviousNext
Back to top
Download PDF
Citation Tools
Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine
Ralph A. Tripp, Larry J. Anderson
Journal of Virology Nov 1998, 72 (11) 8971-8975; DOI:

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
Share
Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine
Ralph A. Tripp, Larry J. Anderson
Journal of Virology Nov 1998, 72 (11) 8971-8975; DOI:
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514